Chongqing Pharscin Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 561.69 million compared to CNY 645.34 million a year ago. Revenue was CNY 561.69 million compared to CNY 645.34 million a year ago.

Net income was CNY 72.85 million compared to CNY 89.44 million a year ago. Basic earnings per share from continuing operations was CNY 0.1816 compared to CNY 0.223 a year ago. Diluted earnings per share from continuing operations was CNY 0.1816 compared to CNY 0.223 a year ago.